Skip to content
DefDex

Federal award

SAREPTA THERAPEUTICS, INC.

HDTRA109C0046

Contract

Obligated and Ceiling

Obligated (net)
$7,707,810.88
Ceiling (potential value, not spending)
$8,785,514.78
Current value
$8,785,514.78
Gross positive obligations
$8,785,514.78

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
SAREPTA THERAPEUTICS, INC. · YKM9HZ3EH6X1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
SAREPTA THERAPEUTICS, INC. · FVMHHCGQKM83
Awarding agency
Department of War · sub-agency 9761 · office HDTRA1
Funding agency
Department of War · sub-agency 9761
Product or service (PSC)
AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
HDTRA109C0046
Award type code
D
Actions
9 · May 5, 2009 to Sep 13, 2021
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History9

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 13, 2021FY2021P00008C$712,017.58
—
Feb 18, 2016FY2016P00007M$0.00
—
Nov 30, 2015FY2016P00006M−$698,971.66
—
Sep 14, 2015FY2015P00005M−$378,732.24
—
Sep 29, 2010FY2010P00004B$0.00
—
Mar 25, 2010FY2010P00003B$3,970,094.20
—
Dec 17, 2009FY2010P00002B$0.00
—
Sep 3, 2009FY2009P00001C$2,103,403.00
—
May 5, 2009FY20090—$2,000,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.